QL
LAB icon

Quarry LP’s Standard BioTools LAB Stock Holding History

Quarry LP’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$940 Buy
+1,143
New +$1.08K ﹤0.01% 1990

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Quarry LP's LAB Position: Q2 2026 in Review

Quarry LP opened a new position in Standard BioTools (LAB) in Q2 2026: 1,143 shares worth $940. The stake represents ﹤0.01% of the portfolio and ranks #1990 among its holdings.

143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Quarry LP held 1,143 shares of Standard BioTools worth $940 as of Q2 2026.
  • Standard BioTools was a new Quarry LP position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1990 holding.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.